Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Diphenylalanine-Based Microribbons for Piezoelectric Applications via Inkjet Printing.

Safaryan S, Slabov V, Kopyl S, Romanyuk K, Bdikin I, Vasilev S, Zelenovskiy P, Shur VY, Uslamin EA, Pidko EA, Vinogradov AV, Kholkin AL.

ACS Appl Mater Interfaces. 2018 Mar 28;10(12):10543-10551. doi: 10.1021/acsami.7b19668. Epub 2018 Mar 15.

PMID:
29498259
2.

Self-Assembly of Organic Ferroelectrics by Evaporative Dewetting: A Case of β-Glycine.

Seyedhosseini E, Romanyuk K, Vasileva D, Vasilev S, Nuraeva A, Zelenovskiy P, Ivanov M, Morozovska AN, Shur VY, Lu H, Gruverman A, Kholkin AL.

ACS Appl Mater Interfaces. 2017 Jun 14;9(23):20029-20037. doi: 10.1021/acsami.7b02952. Epub 2017 Jun 2.

PMID:
28534399
3.

On the origin of the great rigidity of self-assembled diphenylalanine nanotubes.

Zelenovskiy P, Kornev I, Vasilev S, Kholkin A.

Phys Chem Chem Phys. 2016 Nov 2;18(43):29681-29685.

PMID:
27775117
4.

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Mądry R, Christensen RD, Berek JS, Dørum A, Tinker AV, du Bois A, González-Martín A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA; ENGOT-OV16/NOVA Investigators.

N Engl J Med. 2016 Dec 1;375(22):2154-2164. Epub 2016 Oct 7.

5.

Fabric-based exocervical and endocervical biopsy in comparison with punch biopsy and sharp curettage.

Winter M, Cestero RM, Burg A, Felix JC, Han C, Raffo AM, Vasilev S.

J Low Genit Tract Dis. 2012 Apr;16(2):80-7. doi: 10.1097/LGT.0b013e318234262d.

PMID:
22371040
6.

Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer.

Mahdavi A, Tajalli TR, Dalmar A, Vasilev SA, Lentz SE, Berman ML.

Int J Gynecol Cancer. 2011 Nov;21(8):1436-40. doi: 10.1097/IGC.0b013e31822e7588.

PMID:
21997174
7.

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS.

Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.

PMID:
19820372
8.

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):373-8.

PMID:
17362315
9.

Uterine effects of tamoxifen: a prospective study.

McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, Roy S, Wong PT, Simpson JF, Wilczynski SP.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):814-20.

PMID:
16681767
10.

Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers.

Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH.

Gynecol Oncol. 2006 Apr;101(1):120-5. Epub 2005 Nov 22.

PMID:
16307792
11.

Dendritic cells acquire tolerogenic properties at the site of sterile granulomatous inflammation.

Vasilijić S, Savić D, Vasilev S, Vucević D, Gasić S, Majstorović I, Janković S, Colić M.

Cell Immunol. 2005 Feb;233(2):148-57.

PMID:
15978562
12.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.

Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, Disaia PJ.

Gynecol Oncol. 2005 Jan;96(1):204-9.

PMID:
15589602
13.

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.

Cancer Chemother Pharmacol. 2004 Oct;54(4):283-9. Epub 2004 Jun 4.

PMID:
15184995
14.

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML.

Gynecol Oncol. 2003 Jul;90(1):181-5.

PMID:
12821361
15.

Paying for prevention standardizing the measurement of the value of health care interventions.

Vasilev SA.

Obstet Gynecol Clin North Am. 2002 Dec;29(4):613-43, v. Review.

PMID:
12509088
16.

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.

Morgan RJ, Doroshow JH, Leong L, Schriber J, Shibata S, Forman S, Hamasaki V, Margolin K, Somlo G, Alvarnas J, McNamara M, Longmate J, Raschko J, Chow W, Vasilev S, McGonigle K, Yen Y.

Bone Marrow Transplant. 2001 Nov;28(9):859-63.

17.

Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.

Gillette-Cloven N, Burger RA, Monk BJ, McMeekin DS, Vasilev S, DiSaia PJ, Kohler MF.

J Am Coll Surg. 2001 Dec;193(6):626-32.

PMID:
11768679
18.

Ovarian cancer metastatic to the brain: what is the optimal management?

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS.

J Surg Oncol. 2001 Nov;78(3):194-200; discussion 200-1. Review.

PMID:
11745806
19.

Ovarian histopathology in breast cancer patients receiving tamoxifen.

McGonigle KF, Vasilev SA, Odom-Maryon T, Simpson JF.

Gynecol Oncol. 1999 Jun;73(3):402-6.

PMID:
10366467
20.

Cervical Cancer Prevention: Toward Cost-Effective Screening.

McMeekin DS, McGonigle KF, Vasilev SA.

Medscape Womens Health. 1997 Dec;2(12):1.

PMID:
9746710

Supplemental Content

Loading ...
Support Center